Skip to main navigation Skip to search Skip to main content

Patient Adipose Stem Cell-Derived Adipocytes Reveal Genetic Variation that Predicts Antidiabetic Drug Response

  • Wenxiang Hu
  • , Chunjie Jiang
  • , Dongyin Guan
  • , Pieterjan Dierickx
  • , Rong Zhang
  • , Arden Moscati
  • , Girish N. Nadkarni
  • , David J. Steger
  • , Ruth J.F. Loos
  • , Cheng Hu
  • , Weiping Jia
  • , Raymond E. Soccio
  • , Mitchell A. Lazar

Research output: Contribution to journalArticlepeer-review

Abstract

Hu, Jiang, et al. utilize patient adipose stem cell-derived adipocytes to reveal SNPs that modulate the effects of antidiabetic drugs by controlling genomic binding of PPARγ.

Original languageEnglish (US)
Pages (from-to)299-308.e6
JournalCell Stem Cell
Volume24
Issue number2
DOIs
StatePublished - Feb 7 2019
Externally publishedYes

Keywords

  • ABCA1
  • adipocytes
  • adipose stem cell
  • antidiabetic drug
  • drug response
  • genetic variation
  • PPARγ
  • rosiglitazone

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology

Fingerprint

Dive into the research topics of 'Patient Adipose Stem Cell-Derived Adipocytes Reveal Genetic Variation that Predicts Antidiabetic Drug Response'. Together they form a unique fingerprint.

Cite this